Advicenne Ramps Up EU Marketing Plans For Rare Kidney Disease Drug

Sibnayal, Advicenne’s innovative treatment for distal renal tubular acidosis, is set to be approved for use in the EU shortly.

airport runway under the sun as background
Advicenne is gearing up to make its product quickly and broadly available in all EU countries • Source: Shutterstock

More from Europe

More from Geography